Medimmune
  • ABOUT MEDIMMUNE
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • OUR CULTURE
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies & Approaches
    • Partnering
  • VENTURES
    • Investing in Our Future
    • Portfolio
  • PRESS ROOM
  • CAREERS
  • CONTACT
  • Home >
    • News & Media

News and Media

For press releases:

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Receive E-mail alerts

Subscribe to RSS feeds

November 16, 2009
MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition
October 30, 2009
MedImmune to Present Four Abstracts on RSV and Influenza at 47th Annual IDSA Meeting
October 22, 2009
Interim Clinical Trial Results Show MedImmune's H1N1 Vaccine Has Similar Safety Profile as Seasonal Vaccine in Eligible Children and Adults
October 16, 2009
MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
October 15, 2009
MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
September 21, 2009
MedImmune Receives U.S. Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza
August 20, 2009
'Don't Play With the Flu'(TM) Campaign to Coach Families on Playing Defense Against Seasonal Flu
August 10, 2009
MedImmune Advances Three Oncology Programs Into the Clinic
July 28, 2009
FluMist(R) Begins Shipping for 2009-2010 Influenza Season
June 29, 2009
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
June 29, 2009
MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
June 1, 2009
HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
May 5, 2009
MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
May 5, 2009
FluMistĀ® Shows Acceptable Safety Profile in Immunocompromised Children, According to New Findings Presented at Pediatric Academic Societies Annual Meeting
May 4, 2009
MedImmune Awards Five Fellowship Research Grants to Advance Viral Respitory Disease Research
April 16, 2009
MedImmune Showcases Commitment to Cancer Research at Annual Meeting of the American Association for Cancer Research
January 6, 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
  • Terms and Conditions
  • |
  • Privacy Policy
  • |
  • Site Map
  • |
  • Contact Us
  • |
  • Glossary
Copyright © 2009 MedImmune, LLC. All rights reserved.